- Home
- LIXT vs WETH Comparison
LIXT vs WETH Comparison
Compare LIXT & WETH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIXT
- WETH
- Stock Information
- Founded
- LIXT 2005
- WETH 1992
- Country
- LIXT United States
- WETH China
- Employees
- LIXT N/A
- WETH N/A
- Industry
- LIXT Biotechnology: Pharmaceutical Preparations
- WETH
- Sector
- LIXT Health Care
- WETH
- Exchange
- LIXT Nasdaq
- WETH Nasdaq
- Market Cap
- LIXT 12.4M
- WETH 10.9M
- IPO Year
- LIXT N/A
- WETH N/A
- Fundamental
- Price
- LIXT $4.47
- WETH $1.14
- Analyst Decision
- LIXT
- WETH
- Analyst Count
- LIXT 0
- WETH 0
- Target Price
- LIXT N/A
- WETH N/A
- AVG Volume (30 Days)
- LIXT 121.5K
- WETH 195.2K
- Earning Date
- LIXT 08-07-2025
- WETH 09-16-2025
- Dividend Yield
- LIXT N/A
- WETH N/A
- EPS Growth
- LIXT N/A
- WETH N/A
- EPS
- LIXT N/A
- WETH 0.34
- Revenue
- LIXT N/A
- WETH $41,024,264.00
- Revenue This Year
- LIXT N/A
- WETH N/A
- Revenue Next Year
- LIXT N/A
- WETH N/A
- P/E Ratio
- LIXT N/A
- WETH $3.44
- Revenue Growth
- LIXT N/A
- WETH 2.86
- 52 Week Low
- LIXT $0.64
- WETH $0.76
- 52 Week High
- LIXT $5.14
- WETH $2.96
- Technical
- Relative Strength Index (RSI)
- LIXT 58.29
- WETH 62.41
- Support Level
- LIXT $3.20
- WETH $1.06
- Resistance Level
- LIXT $4.60
- WETH $1.29
- Average True Range (ATR)
- LIXT 0.51
- WETH 0.12
- MACD
- LIXT 0.06
- WETH 0.04
- Stochastic Oscillator
- LIXT 78.53
- WETH 67.37
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
About WETH Wetouch Technology Inc.
Wetouch Technology Inc is a touch panel supplier focused on R & D, production and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots and charging stations. The company sells touchscreen products both domestically in China and internationally, covering the majority of areas in China, Taiwan, South Korea, and Germany.